We applied LncSubpathway to the breast cancer subtype dataset and identified risk lncRNA-associated subpathways for each subtype (luminal A, luminal B, HER2, and basal) (Supplementary Tables 2, 3, 4, 5). Here, ERBB2 is linked to breast cancer.